Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACT pilot feasibility study for anticoagulation of calf thrombosis
ISRCTN75175695Phase 4Completed
- Sponsor
- Central Manchester and Manchester Children's Hospitals NHS Trust
- Start
- Jan 2011
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
01
Overview
Phase 4, randomised, open-label trial of dalteparin and warfarin in deep vein thrombosis (DVT) and isolated distal deep vein thrombosis (IDDVT) (2 arms), sponsored by Central Manchester and Manchester Children's Hospitals NHS Trust. Primary endpoint: Combined incidence of thrombus propagation above knee or development of pulmonary embolism. Started Jan 2011; status: completed.
02
Drugs
dalteparinwarfarin
03
Conditions
deep vein thrombosis (DVT)isolated distal deep vein thrombosis (IDDVT)
Beyond the preview
Go deeper on ISRCTN75175695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN75175695.